EcoDrugPlus

Ensembl ID : YGR034W
Description: -
113 Possible Orthologues:

Title

Ensembl ID : YGR108W
Description: -
661 Possible Orthologues:

Title

Ensembl ID : YGR109C
Description: -
656 Possible Orthologues:

Title

Ensembl ID : YGR110W
Description: -
1827 Possible Orthologues:

Title

Ensembl ID : YGR118W
Description: -
117 Possible Orthologues:

Title

Ensembl ID : YGR135W
Description: -
75 Possible Orthologues:

Title

Ensembl ID : YGR138C
Description: -
339 Possible Orthologues:

Title

Ensembl ID : YGR148C
Description: -
93 Possible Orthologues:

Title

Ensembl ID : YGR214W
Description: -
131 Possible Orthologues:

Title

Ensembl ID : YGR218W
Description: -
72 Possible Orthologues:

Title

Ensembl ID : YGR253C
Description: -
102 Possible Orthologues:

Title

Ensembl ID : YGR287C
Description: -
322 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).